Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update.

Anxiety Depression Hospital Anxiety and Depression Scale (HADS) Inflammatory Bowel Disease Patient-Reported Outcome Measurement Information System (PROMIS). Patient-Reported Outcome Measurements (PROMs) Quality of life

Journal

Reviews on recent clinical trials
ISSN: 1876-1038
Titre abrégé: Rev Recent Clin Trials
Pays: United Arab Emirates
ID NLM: 101270873

Informations de publication

Date de publication:
28 Jun 2022
Historique:
received: 08 04 2022
revised: 17 04 2022
accepted: 19 04 2022
entrez: 30 6 2022
pubmed: 1 7 2022
medline: 1 7 2022
Statut: aheadofprint

Résumé

Background Anxiety and depression are the most common psychological disorders found in Inflammatory Bowel Disease (IBD) patients. Accurate measuring of these disorders should be proposed for a prompt management. Patient-reported outcome measurements (PROMs) allow patients to self-report their psychological symptoms. Objective To highlight the presence of PROMs measuring anxiety and depression in IBD setting evaluating the most used psychometric tools. Methods We reviewed the literature from 2010 up to September 2021. Articles on adult IBD patients assessing depression and anxiety by PROMs in English language were included. Results Thirty-six studies, including 11 psychometric tools were found. Hospital Anxiety and Depression Scale (21 studies), Beck Depression Inventory II (5 studies), Spielberg State-Trait Anxiety Inventory (3 studies), Patient-Reported Outcomes Measurement Information System (3 studies), Symptom Checklist-90 (2 studies), Euro Quality of Life (2 studies) mostly used psychometric tools for anxiety and depression in IBD settings. Conclusion Our review analyzed psychometric tools used for PROMs evaluating anxiety and depression in IBD setting. No chronological differences have emerged, all have been used in the last ten years, highlighting a lack of specificity. The strong association between IBD and mood disorders suggests that clinicians should consider the evaluation of depression and anxiety as integral parts of IBD clinical care. It is essential to identify tools enabling these items to be detected better. A global view of IBD patients, accounting not only for physical but also for psychical symptoms with an early and feasible assessment of unrecognized psychiatric disorders, can have a strong impact on their management strategy.

Identifiants

pubmed: 35770406
pii: RRCT-EPUB-124855
doi: 10.2174/1574887117666220628151256
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Rocco Spagnuolo (R)

Department of Clinical and Experimental Medicine, Magna Graecia, University of Catanzaro, Calabria, Catanzaro, Italy.

Antonio Basile (A)

Department of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.

Alessandro Corea (A)

Department of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.

Francesco Salvatore Iaquinta (FS)

Department of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.

Nataša Milić (N)

Department of Pharmacy, University of Novi Sad, Novi Sad, Serbia.

Patrizia Doldo (P)

Department of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.

Francesco Luzza (F)

Department of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.

Ludovico Abenavoli (L)

Department of Health Sciences, Magna Graecia University of Catanzaro, Calabria, Catanzaro, Italy.

Classifications MeSH